OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan ...
OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy announced OptimizeRx’s CEO Will Febbo is invited to speak at the upcoming J.P. Morgan Healthcare Conference. The OPRX conference presentation is scheduled to begin at 8:15 AM PT on January 12, 2023. Ahead of the conference, OPRX is providing the following business update and key industry trends from management’s presentation
By OptimizeRx Corporation
Published - Jan 04, 2023, 07:33 AM ET
Last Updated - Apr 29, 2024, 05:38 AM EDT